Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data

Fig. 4

The correlation between activities of ICIs in RET fusion positive patients and PD-L1 level. (A) maximum Changes in the target lesions based on different PD-L1 levels (B) relationship between PD-L1 expression and efficacy in responders (PR) and non-responders (SD and PD); (C) The correlation between PD-L1 level and maximum changes in target lesions

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us